A Cyanine-Mediated Self-Assembly System for the Construction of a Two-in-One Nanodrug

Angew Chem Int Ed Engl. 2021 Sep 20;60(39):21226-21230. doi: 10.1002/anie.202108393. Epub 2021 Aug 19.

Abstract

The combination of gene therapy and chemotherapy provides a We developed a simple and versatile approach to prepare a series of two-in-one nanodrugs through direct self-assembly of cyanine-labeled single-stranded DNA (Cys-DNA) and different types of drug molecules. Molecular dynamics simulation showed that the Cys introduced into the DNA could enhance the noncovalent interaction between Cys-DNA and drug molecules. More drug molecules were incorporated into Cys-DNA, tending to spontaneously form hybrid Cys-DNA/drug nanosphere. Such nanospheres serve as both carriers and cargoes, excluding the extra use of nontherapeutic excipients and showing ultrahigh drug loading capacity. Following this approach, an antisense oligonucleotides/doxorubicin nanodrug model was constructed, demonstrating the significant synergistic anti-tumor therapeutic effect. As a proof of the concept, our study establishes a simple and reproducible two-in-one nucleic acid-based drug formulation.

Keywords: anti-tumor; cyanine; nanodrugs; self-assembly; two-in-one.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / pharmacology*
  • Carbocyanines / chemistry*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • DNA / chemistry*
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology*
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Dynamics Simulation
  • Nanoparticles / chemistry*
  • Oligonucleotides, Antisense / chemistry
  • Oligonucleotides, Antisense / pharmacology*
  • Particle Size

Substances

  • Antibiotics, Antineoplastic
  • Carbocyanines
  • Oligonucleotides, Antisense
  • Doxorubicin
  • DNA